← Open Payments lookup

FRANCISCA OBODO: Open Payments

NPI 1174270995 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,040 in 56 payments from 12 companies in 2025. Trend: 2023 $692 · 2024 $919 · 2025 $1,040

Food & beverage: $1,040
CompanyPaymentsAmount
ABBVIE INC.22$275
Vanda Pharmaceuticals Inc.7$236
Alkermes, Inc.5$104
Otsuka America Pharmaceutical, Inc.6$93
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$86
Neurocrine BioSciences, Inc.5$77
Axsome Therapeutics, Inc.3$47
Janssen Pharmaceuticals, Inc1$34
E.R. Squibb & Sons, L.L.C.1$24
Supernus Pharmaceuticals, Inc.1$24

Products named: VRAYLAR, FANAPT, ARISTADA, CAPLYTA, INGREZZA, ABILIFY MAINTENA, REXULTI, Auvelity.

Industry payments across MD — which companies pay providers there.